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Prevalence of Gestational Diabetes Mellitus in Sub-Saharan Africa in 2000 and Beyond: A Systematic Review  Eskinder Wolka (BSC, MPH) 1      Wakgari Deressa (PhD)2 1. School of Public Health, Wolaita Sodo University, Ethiopia 2.School of Public Health, Addis Ababa University, Ethiopia  Abstract Introduction:  Gestational diabetes mellitus (GDM) is the common cause of hyperglycaemia in pregnancy, accounting for about 90% of all diabetes during pregnancy. A diabetic pregnant woman and her unborn child are at increased risk of pregnancy complications. Gestational diabetes mellitus has long-term public health significance, contributing to the escalating type 2 diabetes epidemic. Understanding the magnitude of gestational diabetes mellitus in Africa may provide evidence on how interventions should be targeted to reduce the magnitude of the problem, to improve maternal and child health and to reduce the burden of type 2 diabetes in the region. Objective: The aim of this systematic review was to assess the prevalence of Gestational diabetes mellitus in Sub-Saharan AfricaMethods: A systematic computer based literature search was conducted for published papers on gestational diabetes in sub-Saharan Africa in 2000 and beyond. The PRISMA guidelines (Checklist, Moher D. et al 2009 ) for the reporting of systematic reviews were followed. A comprehensive key word search strategy was done in Google scholar and PubMed for terms associated with diabetes and pregnancy and sub-Saharan Africa. Articles Published in English language were included. Data were then extracted regarding country, residence (rural/urban), population group, sample size, age of pregnant women in the cohort, gestational age, how they tested for GDM and what GDM prevalence was reportedResult: We identified 7 studies conducted in five of (about 10% of) the 47 sub-Saharan African countries. Most of the studies conducted in West Africa. It needs more effort to work in the area of GDM in Sub-Saharan Africa since only about 10% of the countries had studies on GDM in the year 2000-2016.  The most commonly employed method for GDM screening in Sub-Saharan Africa is the two hour 75 g OGTT with glucose reference ranges as set by the WHO 1985 or 1999 diagnostic criteria. The percentage of women affected with GDM in this review was as low as 4.8% in Nigeria and as high as 11.6% amongst urban Kenyan women. This review  has  found  some  evidence  of  an  increase  in  the  prevalence  of  GDM in Sub-Saharan Africa. Conclusion: There are few studies on prevalence GDM in sub-Saharan Africa. The most commonly employed method for GDM screening in Sub-Saharan Africa is the two hour 75 g OGTT with glucose reference ranges as set by WHO diagnostic criteria.  The prevalence was high and needs preventive measures to reduce maternal and child complications related to GDM in sub-Saharan Africa. Keywords: Gestational Diabetes Mellitus, Sub-Saharan Africa  Introduction Gestational diabetes mellitus is defined by the World Health Organization as being ‘‘any degree of glucose intolerance with onset or first recognition during pregnancy’’. In recent times, prevalence of hyperglycemia in pregnancy in women 20–49 years was estimated to be 16.9% worldwide and affecting 21.4 million live births, in 2013, and more than 90% of cases are estimated to occur in low- and middle-income countries [1 ]. Gestational diabetes mellitus (GDM) is the common cause of hyperglycaemia in pregnancy, accounting for about 90% of all diabetes during pregnancy [2].  A diabetic pregnant woman and her unborn child are at increased risk of pregnancy complications[3]. Gestational diabetes mellitus has long-term public health significance, contributing to the escalating type 2 diabetes epidemic. Although GDM is a temporary phenomenon for the pregnant woman, more than 50% of women with GDM develop type 2 diabetes within 5-10 years of delivery. Moreover, infants of women with GDM have a higher prevalence of overweight or obesity as young children and adolescents, and a higher risk of developing type 2 diabetes later in life [4].  Review on diabetes in Sub-Saharan Africa included the prevalence of gestational diabetes was not recent and majority of the data used were researches conducted about decades ago. This review aims to investigate the prevalence of Gestational Diabetes mellitus in Sub-Saharan Africa by using more recent evidences and publications from original research conducted in the area.   Objective  The aim of this systematic review was to assess the prevalence of Gestational Diabetes mellitus in Sub-Saharan Africa.   
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Methods  Searching strategy A systematic computer based literature search was conducted for published papers on gestational diabetes in sub-Saharan Africa in 2000 and beyond. The PRISMA guidelines (Checklist, Moher D. et al 2009 ) for the reporting of systematic reviews were followed. A comprehensive key word search strategy was done in Google scholar and PubMed for terms associated with diabetes and pregnancy and sub-Saharan Africa, sub-African region or country specific were used. Articles Published in English language were included. We included original published articles reporting prevalence of GDM in any Sub-Saharan country regardless of screening and diagnostic criteria used, and regardless of method used for selection of participants. Studies which reported only type 1 and/or type 2 diabetes were excluded.  The following search terms and combinations were used: ‘‘gestational diabetes’’ and Sub-Saharan Africa; ‘‘impaired fasting glucose’’ and pregnancy and Sub-Saharan Africa; diabetes and pregnancy and Sub-Saharan Africa; ‘‘impaired glucose tolerance’’ and pregnancy and Sub-Saharan Africa; ‘‘gestational diabetes’’ and ‘‘Sub-Saharan African countries.’’ In addition, the search terms ‘‘gestational diabetes,’’ together with the names of each individual country in Sub-Saharan Africa were used. For example, ‘‘gestational diabetes’’ and Nigeria; ‘‘gestational diabetes’’ and Tanzania; ‘‘gestational diabetes’’ and ‘‘South Africa’’ were entered into the search. The list of all recognized Sub-Saharan Africa countries included in the search.   Study selection First titles of articles were retrieved based on search terms and abstracts were obtained, the abstracts were reviewed and finally all articles found to be eligible for full document review were reviewed in detail.  Data Extraction Full text articles were obtained and reviewed. Data were then extracted regarding country, region (rural/urban), population group, sample size, age of pregnant women in the cohort, gestational age, how they tested for GDM and what GDM prevalence was reported. In addition, data were also extracted from abstracts that included how GDM was screened for, what criteria were used and what prevalence figures were obtained in the study but for which full text articles could not be obtained. The most recognized diagnostic test for GDM is the oral glucose tolerance test (OGTT) usually performed between 24–28 weeks gestation [5]. Different screening regimes for GDM exist and as a result studies investigating prevalence of GDM are often diverse in terms of methods employed, cut-off values used and consequently, results obtained [6].  Table 1 summarizes some of the different screening regimes and respective glucose cut-off values used to diagnose GDM.   
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Table 1: Diagnostic criteria used to diagnose GDM. No. Organization  Screening test  Blood Glucose threshold Diagnostic criteria 1 WHO 1985[7] 2 hr 75g OGTT Fasting ≥7.8 mmol/L  2 hr ≥11.1 mmol/L At least one 2 WHO 1999[8] 2 hr 75g OGTT Fasting ≥7.0 mmol/L  2 hr ≥7.8 mmol/L At least one 3 WHO 2013[9] 2 hr 75g OGTT Fasting: 5.1-6.9 mmol/L 1 hr ≥10 mmol/L 2 hrs ≥8.5-11.0 mmol/L At least one 4 International Association of Diabetes and Pregnancy Study Group (IADPSG)[10] 75g OGTT Fasting 5.1-6.9 mmol/L  1 hr ≥ 10 mmol/L 2 hr ≥ 8.5-11.0 mmol/L At least one  5 American Diabetes Association (ADA)[11] Two steps  Step 1   50 g (1 hr ≥ 7.8 mmol/L)  Fasting 5.3 mmol/L 1 hr ≥ 10.0 mmol/L 2 hrs ≥ 8.6 mmol/L 3 hr ≥ 7.8 mmol/L Two or more  Step 2  100g OGTT Fasting ≥5.8 mmol/L  1 hr ≥ 10.6 mmol/L 2 hr ≥ 9.2 mmol/L 3 hr ≥ 8.0 mmol/L   One step: 75g OGTT Fasting ≥5.3 mmol/L 1 hr ≥ 10 mmol/L 2 hrs ≥8.6 mmol/L At least one  6 Australian Diabetes Association In Pregnancy Society (ADIPSI)[12] 75g OGTT Fasting ≥5.1 mmol/L  1 hr ≥ 10 mmol/L 2 hr ≥ 8.5-11.0 mmol/L At least one 7 Diabetes In Pregnancy Study Group India (DIPSI)[13] 75g OGTT 2 hr ≥7.8 mmol/L Only one  8 Diabetes Pregnancy Study Group (DPSG)[14] 75g OGTT Fasting >5.2 mmol/L  2 hr ≥ 9.0 mmol/L At least one 9 National Diabetes Data Group (NDDG)[15] 3 hr 100g OGTT Fasting ≥5.8 mmol/L 1 hr ≥10.6 mmol/L 2 hrs ≥9.2 mmol/L 3 hrs ≥ 8.0 mmol/L At least two  Result and Discussion  The review included studies conducted within the previous 16 years (2000–2016).Initially, total of 962 articles identified by data base searching search terms. For total retrieved articles, titles and abstracts were reviewed and 895 articles were excluded because they were not relevant after title screening, 54 conducted before 2000 and objectives of the studies were not the interest of review after reviewing abstract and 6 studies conducted outside Sub-Saharan Africa. Finally seven articles were obtained for final review. 
 This systematic review focused on studies in Sub-Saharan African countries that provided information 
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on the GDM screening methods employed, the diagnostic criteria used and the prevalence figures obtained. We identified 7 studies conducted in five of (about 10% of) the 47 sub-Saharan African countries. Most of the studies conducted in West Africa. This shows very few studies conducted in Sub-Saharan Africa when compared with review conducted in Europe which included 23 countries. Based on this systematic review, it needs more effort to work in the area of GDM in Sub-Saharan Africa since only about 10% of the countries had studies on GDM in the year 2000-2016.  More epidemiological based studies on GDM in Sub-Saharan African countries need to be performed in order to provide reliable information and thus clarity on the extent of GDM.  For effective delivery of maternal and child health services related to GDM, detail understanding of the problem is vital.  As GDM often results in macrosomic infants, birth trauma and the need for Caesarean sections at delivery are expected. This is precarious as it impacts both maternal and child survival during delivery, and places a significant economic burden on the health system, which in many African countries is already struggling with limited resources.  The most commonly employed method for GDM screening in Sub-Saharan Africa is the two hour 75 g OGTT with glucose reference ranges as set by the WHO 1985 or 1999 diagnostic criteria. One of the reported studies used National Diabetes Data Group (NDDG) criteria. This finding is consistent with review conducted in Europe, most studies used World Health Organization criteria for screening and diagnosing gestational diabetes. National Diabetes Data Group criteria were less often used.  The percentage of women affected with GDM in this review was as low as 4.8% in Nigeria and as high as 11.6% amongst urban Kenyan women. The prevalence is higher when compared with the review conducted in Europe which ranges from 2-6%. This review  has  found  some  evidence  of  an  increase  in  the  prevalence  of  GDM in Sub-Saharan Africa.   Conclusion  There are few studies on prevalence GDM in sub-Saharan Africa. The most commonly employed method for GDM screening in Sub-Saharan Africa is the two hour 75 g OGTT with glucose reference ranges as set by WHO diagnostic criteria.  The prevalence was high and needs preventive measures to reduce maternal and child complications related to GDM in sub-Saharan Africa.   Conflict of interest  The author(s) declare that we have no competing interests. Table 2; General characteristics of studies included in systematic review[16-22] S.N Author/s Year  Country  Setting  Study design  Population  Screening criteria  Prevalence of GDM 1 Ewenighi Chinwe O. et al 2011 Nigeria  Urban  Cross sectional  250 National  Diabetes  Data  Group  (NDDG)  criteria 4.8  2 Olarinoye et al.  2004 Nigeria  Urban  Prospective cohort 293 WHO 6.45 3 Akwilina  W. et al 2012 Tanzania  Urban and Rural  Cross sectional  910 WHO 5.9  4 Bosire A.N, Joseph K. 2011 Kenya  Urban  Cross sectional 371 WHO 11.6 5 Anzaka AS, Musa J. 2009 Nigeria  Urban  Cross sectional  265 WHO 8.3 6 R. L. Mamabolo et al 2000 South Africa  Semi-Rural  Cross sectional  262 WHO 8.8 7 Jennifer Jao et al 2013 Cameroon  Semi-Urban  Cross sectional 316 WHO 6.3  References  1. IDF.  International Diabetes Federation.  Diabetes Atlas, 6th Edition. International Diabetes Federation: Brussels, Belgium, 2013 2.  ADA. Diagnosis and classification of diabetes mellitus. Diabetes Care, 2004  3. Moore T, S.C., Diabetes Mellitus and Pregnancy. Medscape drugs, diseases and procedures reference; 2012. 4. Kim C, N.K., Knopp RH., Gestational Diabetes and the Incidence of Type 2 Diabetes: A Systematic Review,. Diabetes Care 25, 2002. 5.  Farrar D, Duley L, Lawlor DA (2012) Different strategies for diagnosing gestational diabetes to improve maternal and infant health. Cochrane Database Syst Rev: CD007122. 
Journal of Biology, Agriculture and Healthcare                                                                                                                                www.iiste.org ISSN 2224-3208 (Paper)  ISSN 2225-093X (Online) Vol.7, No.9, 2017  
5 
6. Nielsen KK, de Courten M, Kapur A (2012) The urgent need for universally applicable simple screening procedures and diagnostic criteria for gestational diabetes mellitus–lessons from projects funded by the World Diabetes Foundation. Glob Health Action 5. 7. WHO, Diabetes mellitus. Report of a WHO Study Group. World Health Organ Tech Rep Ser., 1985. 8. WHO, Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation group. Part 1: Diagnosis and classification of diabetes mellitus. WHO Geneva., 1999 9. WHO, Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy, World Health Organisation, Geneva. 2013. 10. Metzger BE, G.S., Persson B, Buchanan TA, Catalano PA, Damm P, et al, International association of diabetes and pregnancy study groups recommendations 11. ADA, Standards of medical care in diabetes--2014. Diabetes Care, 2014. 12. Nankervis A, M.H., Moses RG, Ross GP, Callaway LK., Testing for Gestational Diabetes Mellitus in Australia. Diabetes Care, 2013. 36. 13. Anjalakshi C, B.V., Balaji MS, Ashalata S, Suganthi S, Arthi T, et al., A single test procedure to diagnose gestational diabetes mellitus. Acta Diabetol, 2009. 46. 14. Editorial, Glucose Tolerance in Pregnancy the- Who and How of Testing. The Lancet, 1988. 332. 15. GroupNDD, Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes., 1979. 28(12). 16. Ewenighi Chinwe O. et al. Prevalence Of Gestational Diabetes Mellitus; Risk Factors Among Pregnant Women (In Abakaliki Metropolis, Ebonyi State Nigeria). NJIRM 4(1). 2013. 17. Olarinoye J, Ohwovoriole A, Ajayi G. Diagnosis of gestational diabetes mellitus in Nigerian pregnant womencomparison between 75 g and 100 g oral glucose tolerance tests. West Afr J Med 2004; 23 18. Akwilina W. et al. Prevalence of gestational diabetes mellitus in urban and rural Tanzania. Diabetes Research and Clinical practice. 103;2014, 71-78.  19. Bosire A.N, Joseph K. Screening of Gestational Diabetes in Kenyatta National Hospital. 2011 20. Anzaku AS., Musa J. Prevalence and associated risk factors for gestational diabetes in Jos, North-central, Nigeria. Arch Gynecol Obstet. 2013 21. R. L. Mamabolo et al. Prevalence of gestational diabetes mellitus and the effect of weight on measures of insulin secretion and insulin resistance in third-trimester pregnant rural women residing in the Central Region of Limpopo Province, South Africa. Diabetic Medicine, 24. 2006. 22. Jennifer J. et al. Gestational Diabetes Mellitus in HIV-Infected and –Uninfected Pregnant Women in Cameroon. Diabetes care, 36. 2013    
